E-LIB Suche - Ergebnisse für: Takemura, Miki

1

In vivoefficacy & resistance prevention of cefiderocol in c..:

Gill, Christian M ; Santini, Debora ; Takemura, Miki...
Journal of Antimicrobial Chemotherapy. 78 (2023) 4 - p. 983-990 , 2023

Link: https://doi.org/10.1093/..

2

2112. In vitro Activity of Cefiderocol and Comparator Agent..:

Bryowsky, Jason J ; DeJonge, Boudewijn L ; Nguyen, Sean T...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

3

In vitro activity of cefiderocol against MBL-producing Gram..:

Takemura, Miki ; Wise, Mark G ; Hackel, Meredith A..
Journal of Antimicrobial Chemotherapy. 78 (2023) 8 - p. 2019-2027 , 2023

Link: https://doi.org/10.1093/..

4

In vitroandin vivoactivity of cefiderocol againstAchromobac..:

Takemura, Miki ; Nakamura, Rio ; Ota, Merime...
Antimicrobial Agents and Chemotherapy. 67 (2023) 12 - p. , 2023

Link: https://doi.org/10.1128/..

5

In vitroefficacy of humanized regimen of flomoxef against e..:

Yamashiro, Hidenori ; Kasamatsu, Yu ; Anan, Naomi...
Antimicrobial Agents and Chemotherapy. 67 (2023) 9 - p. , 2023

Link: https://doi.org/10.1128/..

6

2790. Activity of Cefiderocol and Comparator Agents Against..:

Nguyen, Sean T ; DeJonge, Boudewijn L ; Bryowsky, Jason J...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

7

2762. Activity of Cefiderocol and Comparator Agents Against..:

DeJonge, Boudewijn L ; Nguyen, Sean T ; Bryowsky, Jason J...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

8

Heteroresistance to cefiderocol in carbapenem-resistantAcin..:

Longshaw, Christopher ; Santerre Henriksen, Anne ; Dressel, Dana...
Microbiology Spectrum. 11 (2023) 6 - p. , 2023

Link: https://doi.org/10.1128/..

9

2791. Antimicrobial Activity of Cefiderocol and Comparator ..:

Nguyen, Sean T ; Valencia, Calbert ; Bryowsky, Jason J...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

10

603. Determining Effect of Media and Disk Source on Reprodu..:

Takemura, Miki ; Saiki, Mizue ; Yamashiro, Hidenori...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

11

In vitro antibacterial activities of cefiderocol against Gr..:

Kohira, Naoki ; Hackel, Meredith A ; Oota, Merime...
Journal of Global Antimicrobial Resistance. 32 (2023) - p. 181-186 , 2023

Link: https://doi.org/10.1016/..

12

2761. Activity of Cefiderocol and Comparator Agents Against..:

DeJonge, Boudewijn L ; Nguyen, Sean T ; Bryowsky, Jason J...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

13

Cefiderocol: EUCAST criteria for disc diffusion and broth m..:

Matuschek, Erika ; Longshaw, Christopher ; Takemura, Miki..
Journal of Antimicrobial Chemotherapy. 77 (2022) 6 - p. 1662-1669 , 2022

Link: https://doi.org/10.1093/..

14

1715. In Vitro Antibacterial Activity of Cefiderocol agains..:

Yamano, Yoshinori ; Takemura, Miki ; Shortridge, Dee...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

15

1721. In Vitro Activity of Cefiderocol against IMP-Producin..:

Yamashiro, Hidenori ; Nakai, Ryuichiro ; Takemura, Miki.
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..